WELUNATE Trademark

Trademark Overview


On Wednesday, July 3, 2013, a trademark application was filed for WELUNATE with the United States Patent and Trademark Office. The USPTO has given the WELUNATE trademark a serial number of 86001897. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 20, 2017. This trademark is owned by Eli Lilly and Company. The WELUNATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; diagnostic agents, preparations and substances for medical purposes; radiopharmaceutical diag...
welunate

General Information


Serial Number86001897
Word MarkWELUNATE
Filing DateWednesday, July 3, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; diagnostic agents, preparations and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, February 21, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, July 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2016EXTENSION 5 GRANTED
Tuesday, June 28, 2016EXTENSION 5 FILED
Tuesday, June 28, 2016TEAS EXTENSION RECEIVED
Wednesday, September 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 29, 2015EXTENSION 4 GRANTED
Friday, September 18, 2015EXTENSION 4 FILED
Friday, September 18, 2015TEAS EXTENSION RECEIVED
Friday, July 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 16, 2015EXTENSION 3 GRANTED
Wednesday, July 1, 2015EXTENSION 3 FILED
Wednesday, July 1, 2015TEAS EXTENSION RECEIVED
Friday, February 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 5, 2015EXTENSION 2 GRANTED
Friday, December 12, 2014EXTENSION 2 FILED
Wednesday, February 4, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 12, 2014TEAS EXTENSION RECEIVED
Thursday, June 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 10, 2014EXTENSION 1 GRANTED
Tuesday, June 10, 2014EXTENSION 1 FILED
Tuesday, June 10, 2014TEAS EXTENSION RECEIVED
Tuesday, January 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 2, 2013ASSIGNED TO EXAMINER
Monday, July 15, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 6, 2013NEW APPLICATION ENTERED IN TRAM